US Patent Issued to DemeRx on June 16 for "Methods for the non-toxic treatment for opioid drug withdrawal combining noribogaine and cannabinoids" (Florida Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,831, issued on June 16, was assigned to DemeRx Inc. (Miami).

"Methods for the non-toxic treatment for opioid drug withdrawal combining noribogaine and cannabinoids" was invented by Philip Sigel (Coral Gables, Fla.), Deborah Mash (Coral Gables, Fla.) and Pascal Goldschmidt (Miami).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to the treatment of chemical substance abuse and withdrawal symptoms, especially withdrawal symptoms associated with opioids, utilizing a combination of an effective amount of a cannabinoid, in particular, cannabidiol (CBD) and/or A9-tetrahydrocannabinol (THC) in combination with low dosage nori...